Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. EBITDA 2015–2025
Syndax Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from to 2019. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Syndax Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2019 was -15.0 M, a 24.34% decrease year-over-year.
- Syndax Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2019 was -56.7 M.
EBITDA
QUARTERLY · $B
Syndax Pharmaceuticals Inc. EBITDA — FAQ
Syndax Pharmaceuticals Inc. (SNDX) ebitda over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNDX's ebitda history?
The chart and table above show Syndax Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.